 | • レポートコード：MRC2-11QY02363 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルツハイマー病治療のグローバル市場について調査・分析したレポートです。種類別（メマンチン塩酸塩、ドネペジル塩酸塩、リバスチグミン、ガランタミン臭化水素酸塩）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルツハイマー病治療の競争状況、市場シェア ・世界のアルツハイマー病治療市場：種類別市場規模 2015年-2020年（メマンチン塩酸塩、ドネペジル塩酸塩、リバスチグミン、ガランタミン臭化水素酸塩） ・世界のアルツハイマー病治療市場：種類別市場規模予測 2021年-2026年（メマンチン塩酸塩、ドネペジル塩酸塩、リバスチグミン、ガランタミン臭化水素酸塩） ・世界のアルツハイマー病治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界のアルツハイマー病治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米のアルツハイマー病治療市場分析：米国、カナダ ・ヨーロッパのアルツハイマー病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルツハイマー病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルツハイマー病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルツハイマー病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc、Novartis International AG、Axovant Sciences Ltd、Acadia Pharmaceuticals, Inc、Biotie Therapies、Astra Zeneca plc、Eli Lilly, Inc、F. Hoffman Le Roche、Merck & Co、H. Lundbeck A/S、Takeda Pharmaceutical Company Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alzheimer’s Therapeutic Market
The global Alzheimer’s Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alzheimer’s Therapeutic Scope and Market Size
Alzheimer’s Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alzheimer’s Therapeutic market is segmented into
Memantine Hydrochloride
Donepezil Hydrochloride
Rivastigmine
Galantamine Hydrobromide
Segment by Application, the Alzheimer’s Therapeutic market is segmented into
Hospitals
Clinic
Other
Regional and Country-level Analysis
The Alzheimer’s Therapeutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alzheimer’s Therapeutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alzheimer’s Therapeutic Market Share Analysis
Alzheimer’s Therapeutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alzheimer’s Therapeutic business, the date to enter into the Alzheimer’s Therapeutic market, Alzheimer’s Therapeutic product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Novartis International AG
Axovant Sciences Ltd
Acadia Pharmaceuticals, Inc
Biotie Therapies
Astra Zeneca plc
Eli Lilly, Inc
F. Hoffman Le Roche
Merck & Co
H. Lundbeck A/S
Takeda Pharmaceutical Company Ltd
1 Study Coverage
1.1 Alzheimer’s Therapeutic Product Introduction
1.2 Market Segments
1.3 Key Alzheimer’s Therapeutic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Type
1.4.2 Memantine Hydrochloride
1.4.3 Donepezil Hydrochloride
1.4.4 Rivastigmine
1.4.5 Galantamine Hydrobromide
1.5 Market by Application
1.5.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alzheimer’s Therapeutic Market Size, Estimates and Forecasts
2.1.1 Global Alzheimer’s Therapeutic Revenue 2015-2026
2.1.2 Global Alzheimer’s Therapeutic Sales 2015-2026
2.2 Global Alzheimer’s Therapeutic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alzheimer’s Therapeutic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alzheimer’s Therapeutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alzheimer’s Therapeutic Competitor Landscape by Players
3.1 Alzheimer’s Therapeutic Sales by Manufacturers
3.1.1 Alzheimer’s Therapeutic Sales by Manufacturers (2015-2020)
3.1.2 Alzheimer’s Therapeutic Sales Market Share by Manufacturers (2015-2020)
3.2 Alzheimer’s Therapeutic Revenue by Manufacturers
3.2.1 Alzheimer’s Therapeutic Revenue by Manufacturers (2015-2020)
3.2.2 Alzheimer’s Therapeutic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alzheimer’s Therapeutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alzheimer’s Therapeutic Revenue in 2019
3.2.5 Global Alzheimer’s Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alzheimer’s Therapeutic Price by Manufacturers
3.4 Alzheimer’s Therapeutic Manufacturing Base Distribution, Product Types
3.4.1 Alzheimer’s Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alzheimer’s Therapeutic Product Type
3.4.3 Date of International Manufacturers Enter into Alzheimer’s Therapeutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alzheimer’s Therapeutic Market Size by Type (2015-2020)
4.1.1 Global Alzheimer’s Therapeutic Sales by Type (2015-2020)
4.1.2 Global Alzheimer’s Therapeutic Revenue by Type (2015-2020)
4.1.3 Alzheimer’s Therapeutic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alzheimer’s Therapeutic Market Size Forecast by Type (2021-2026)
4.2.1 Global Alzheimer’s Therapeutic Sales Forecast by Type (2021-2026)
4.2.2 Global Alzheimer’s Therapeutic Revenue Forecast by Type (2021-2026)
4.2.3 Alzheimer’s Therapeutic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alzheimer’s Therapeutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alzheimer’s Therapeutic Market Size by Application (2015-2020)
5.1.1 Global Alzheimer’s Therapeutic Sales by Application (2015-2020)
5.1.2 Global Alzheimer’s Therapeutic Revenue by Application (2015-2020)
5.1.3 Alzheimer’s Therapeutic Price by Application (2015-2020)
5.2 Alzheimer’s Therapeutic Market Size Forecast by Application (2021-2026)
5.2.1 Global Alzheimer’s Therapeutic Sales Forecast by Application (2021-2026)
5.2.2 Global Alzheimer’s Therapeutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Alzheimer’s Therapeutic Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alzheimer’s Therapeutic by Country
6.1.1 North America Alzheimer’s Therapeutic Sales by Country
6.1.2 North America Alzheimer’s Therapeutic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alzheimer’s Therapeutic Market Facts & Figures by Type
6.3 North America Alzheimer’s Therapeutic Market Facts & Figures by Application
7 Europe
7.1 Europe Alzheimer’s Therapeutic by Country
7.1.1 Europe Alzheimer’s Therapeutic Sales by Country
7.1.2 Europe Alzheimer’s Therapeutic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alzheimer’s Therapeutic Market Facts & Figures by Type
7.3 Europe Alzheimer’s Therapeutic Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alzheimer’s Therapeutic by Region
8.1.1 Asia Pacific Alzheimer’s Therapeutic Sales by Region
8.1.2 Asia Pacific Alzheimer’s Therapeutic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alzheimer’s Therapeutic Market Facts & Figures by Type
8.3 Asia Pacific Alzheimer’s Therapeutic Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alzheimer’s Therapeutic by Country
9.1.1 Latin America Alzheimer’s Therapeutic Sales by Country
9.1.2 Latin America Alzheimer’s Therapeutic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alzheimer’s Therapeutic Market Facts & Figures by Type
9.3 Central & South America Alzheimer’s Therapeutic Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alzheimer’s Therapeutic by Country
10.1.1 Middle East and Africa Alzheimer’s Therapeutic Sales by Country
10.1.2 Middle East and Africa Alzheimer’s Therapeutic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alzheimer’s Therapeutic Market Facts & Figures by Type
10.3 Middle East and Africa Alzheimer’s Therapeutic Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Alzheimer’s Therapeutic Products Offered
11.1.5 Pfizer Inc Related Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Corporation Information
11.2.2 Novartis International AG Description and Business Overview
11.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG Alzheimer’s Therapeutic Products Offered
11.2.5 Novartis International AG Related Developments
11.3 Axovant Sciences Ltd
11.3.1 Axovant Sciences Ltd Corporation Information
11.3.2 Axovant Sciences Ltd Description and Business Overview
11.3.3 Axovant Sciences Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Products Offered
11.3.5 Axovant Sciences Ltd Related Developments
11.4 Acadia Pharmaceuticals, Inc
11.4.1 Acadia Pharmaceuticals, Inc Corporation Information
11.4.2 Acadia Pharmaceuticals, Inc Description and Business Overview
11.4.3 Acadia Pharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Products Offered
11.4.5 Acadia Pharmaceuticals, Inc Related Developments
11.5 Biotie Therapies
11.5.1 Biotie Therapies Corporation Information
11.5.2 Biotie Therapies Description and Business Overview
11.5.3 Biotie Therapies Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biotie Therapies Alzheimer’s Therapeutic Products Offered
11.5.5 Biotie Therapies Related Developments
11.6 Astra Zeneca plc
11.6.1 Astra Zeneca plc Corporation Information
11.6.2 Astra Zeneca plc Description and Business Overview
11.6.3 Astra Zeneca plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Astra Zeneca plc Alzheimer’s Therapeutic Products Offered
11.6.5 Astra Zeneca plc Related Developments
11.7 Eli Lilly, Inc
11.7.1 Eli Lilly, Inc Corporation Information
11.7.2 Eli Lilly, Inc Description and Business Overview
11.7.3 Eli Lilly, Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly, Inc Alzheimer’s Therapeutic Products Offered
11.7.5 Eli Lilly, Inc Related Developments
11.8 F. Hoffman Le Roche
11.8.1 F. Hoffman Le Roche Corporation Information
11.8.2 F. Hoffman Le Roche Description and Business Overview
11.8.3 F. Hoffman Le Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Products Offered
11.8.5 F. Hoffman Le Roche Related Developments
11.9 Merck & Co
11.9.1 Merck & Co Corporation Information
11.9.2 Merck & Co Description and Business Overview
11.9.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck & Co Alzheimer’s Therapeutic Products Offered
11.9.5 Merck & Co Related Developments
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Corporation Information
11.10.2 H. Lundbeck A/S Description and Business Overview
11.10.3 H. Lundbeck A/S Sales, Revenue and Gross Margin (2015-2020)
11.10.4 H. Lundbeck A/S Alzheimer’s Therapeutic Products Offered
11.10.5 H. Lundbeck A/S Related Developments
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Alzheimer’s Therapeutic Products Offered
11.1.5 Pfizer Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alzheimer’s Therapeutic Market Estimates and Projections by Region
12.1.1 Global Alzheimer’s Therapeutic Sales Forecast by Regions 2021-2026
12.1.2 Global Alzheimer’s Therapeutic Revenue Forecast by Regions 2021-2026
12.2 North America Alzheimer’s Therapeutic Market Size Forecast (2021-2026)
12.2.1 North America: Alzheimer’s Therapeutic Sales Forecast (2021-2026)
12.2.2 North America: Alzheimer’s Therapeutic Revenue Forecast (2021-2026)
12.2.3 North America: Alzheimer’s Therapeutic Market Size Forecast by Country (2021-2026)
12.3 Europe Alzheimer’s Therapeutic Market Size Forecast (2021-2026)
12.3.1 Europe: Alzheimer’s Therapeutic Sales Forecast (2021-2026)
12.3.2 Europe: Alzheimer’s Therapeutic Revenue Forecast (2021-2026)
12.3.3 Europe: Alzheimer’s Therapeutic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alzheimer’s Therapeutic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alzheimer’s Therapeutic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alzheimer’s Therapeutic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alzheimer’s Therapeutic Market Size Forecast by Region (2021-2026)
12.5 Latin America Alzheimer’s Therapeutic Market Size Forecast (2021-2026)
12.5.1 Latin America: Alzheimer’s Therapeutic Sales Forecast (2021-2026)
12.5.2 Latin America: Alzheimer’s Therapeutic Revenue Forecast (2021-2026)
12.5.3 Latin America: Alzheimer’s Therapeutic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alzheimer’s Therapeutic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alzheimer’s Therapeutic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alzheimer’s Therapeutic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alzheimer’s Therapeutic Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alzheimer’s Therapeutic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alzheimer’s Therapeutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alzheimer’s Therapeutic Market Segments
Table 2. Ranking of Global Top Alzheimer’s Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alzheimer’s Therapeutic Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Memantine Hydrochloride
Table 5. Major Manufacturers of Donepezil Hydrochloride
Table 6. Major Manufacturers of Rivastigmine
Table 7. Major Manufacturers of Galantamine Hydrobromide
Table 8. Global Alzheimer’s Therapeutic Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Alzheimer’s Therapeutic Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Alzheimer’s Therapeutic Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Alzheimer’s Therapeutic Sales Market Share by Regions (2015-2020)
Table 12. Global Alzheimer’s Therapeutic Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Alzheimer’s Therapeutic Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Alzheimer’s Therapeutic Sales Share by Manufacturers (2015-2020)
Table 15. Global Alzheimer’s Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Alzheimer’s Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Therapeutic as of 2019)
Table 17. Alzheimer’s Therapeutic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Alzheimer’s Therapeutic Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Alzheimer’s Therapeutic Price (2015-2020) (USD/Pcs)
Table 20. Alzheimer’s Therapeutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Alzheimer’s Therapeutic Product Type
Table 22. Date of International Manufacturers Enter into Alzheimer’s Therapeutic Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 25. Global Alzheimer’s Therapeutic Sales Share by Type (2015-2020)
Table 26. Global Alzheimer’s Therapeutic Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Alzheimer’s Therapeutic Revenue Share by Type (2015-2020)
Table 28. Alzheimer’s Therapeutic Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 30. Global Alzheimer’s Therapeutic Sales Share by Application (2015-2020)
Table 31. North America Alzheimer’s Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 32. North America Alzheimer’s Therapeutic Sales Market Share by Country (2015-2020)
Table 33. North America Alzheimer’s Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Alzheimer’s Therapeutic Revenue Market Share by Country (2015-2020)
Table 35. North America Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 36. North America Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Table 37. North America Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 38. North America Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Table 39. Europe Alzheimer’s Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Alzheimer’s Therapeutic Sales Market Share by Country (2015-2020)
Table 41. Europe Alzheimer’s Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Alzheimer’s Therapeutic Revenue Market Share by Country (2015-2020)
Table 43. Europe Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Table 45. Europe Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Alzheimer’s Therapeutic Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Alzheimer’s Therapeutic Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Alzheimer’s Therapeutic Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Table 55. Latin America Alzheimer’s Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Alzheimer’s Therapeutic Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Alzheimer’s Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Alzheimer’s Therapeutic Revenue Market Share by Country (2015-2020)
Table 59. Latin America Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Table 61. Latin America Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Alzheimer’s Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Table 71. Pfizer Inc Corporation Information
Table 72. Pfizer Inc Description and Major Businesses
Table 73. Pfizer Inc Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Pfizer Inc Product
Table 75. Pfizer Inc Recent Development
Table 76. Novartis International AG Corporation Information
Table 77. Novartis International AG Description and Major Businesses
Table 78. Novartis International AG Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Novartis International AG Product
Table 80. Novartis International AG Recent Development
Table 81. Axovant Sciences Ltd Corporation Information
Table 82. Axovant Sciences Ltd Description and Major Businesses
Table 83. Axovant Sciences Ltd Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Axovant Sciences Ltd Product
Table 85. Axovant Sciences Ltd Recent Development
Table 86. Acadia Pharmaceuticals, Inc Corporation Information
Table 87. Acadia Pharmaceuticals, Inc Description and Major Businesses
Table 88. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Acadia Pharmaceuticals, Inc Product
Table 90. Acadia Pharmaceuticals, Inc Recent Development
Table 91. Biotie Therapies Corporation Information
Table 92. Biotie Therapies Description and Major Businesses
Table 93. Biotie Therapies Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Biotie Therapies Product
Table 95. Biotie Therapies Recent Development
Table 96. Astra Zeneca plc Corporation Information
Table 97. Astra Zeneca plc Description and Major Businesses
Table 98. Astra Zeneca plc Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Astra Zeneca plc Product
Table 100. Astra Zeneca plc Recent Development
Table 101. Eli Lilly, Inc Corporation Information
Table 102. Eli Lilly, Inc Description and Major Businesses
Table 103. Eli Lilly, Inc Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Eli Lilly, Inc Product
Table 105. Eli Lilly, Inc Recent Development
Table 106. F. Hoffman Le Roche Corporation Information
Table 107. F. Hoffman Le Roche Description and Major Businesses
Table 108. F. Hoffman Le Roche Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. F. Hoffman Le Roche Product
Table 110. F. Hoffman Le Roche Recent Development
Table 111. Merck & Co Corporation Information
Table 112. Merck & Co Description and Major Businesses
Table 113. Merck & Co Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Merck & Co Product
Table 115. Merck & Co Recent Development
Table 116. H. Lundbeck A/S Corporation Information
Table 117. H. Lundbeck A/S Description and Major Businesses
Table 118. H. Lundbeck A/S Alzheimer’s Therapeutic Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. H. Lundbeck A/S Product
Table 120. H. Lundbeck A/S Recent Development
Table 121. Takeda Pharmaceutical Company Ltd Corporation Information
Table 122. Takeda Pharmaceutical Company Ltd Description and Major Businesses
Table 123. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Takeda Pharmaceutical Company Ltd Product
Table 125. Takeda Pharmaceutical Company Ltd Recent Development
Table 126. Global Alzheimer’s Therapeutic Sales Forecast by Regions (2021-2026) (K Pcs)
Table 127. Global Alzheimer’s Therapeutic Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Alzheimer’s Therapeutic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Alzheimer’s Therapeutic Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Alzheimer’s Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. North America: Alzheimer’s Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Alzheimer’s Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Europe: Alzheimer’s Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Alzheimer’s Therapeutic Sales Forecast by Region (2021-2026) (K Pcs)
Table 135. Asia Pacific: Alzheimer’s Therapeutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Alzheimer’s Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. Latin America: Alzheimer’s Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Alzheimer’s Therapeutic Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Middle East and Africa: Alzheimer’s Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Alzheimer’s Therapeutic Players
Table 144. Alzheimer’s Therapeutic Customers List
Table 145. Alzheimer’s Therapeutic Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer’s Therapeutic Product Picture
Figure 2. Global Alzheimer’s Therapeutic Sales Market Share by Type in 2020 & 2026
Figure 3. Memantine Hydrochloride Product Picture
Figure 4. Donepezil Hydrochloride Product Picture
Figure 5. Rivastigmine Product Picture
Figure 6. Galantamine Hydrobromide Product Picture
Figure 7. Global Alzheimer’s Therapeutic Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinic
Figure 10. Other
Figure 11. Alzheimer’s Therapeutic Report Years Considered
Figure 12. Global Alzheimer’s Therapeutic Market Size 2015-2026 (US$ Million)
Figure 13. Global Alzheimer’s Therapeutic Sales 2015-2026 (K Pcs)
Figure 14. Global Alzheimer’s Therapeutic Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Alzheimer’s Therapeutic Sales Market Share by Region (2015-2020)
Figure 16. Global Alzheimer’s Therapeutic Sales Market Share by Region in 2019
Figure 17. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2015-2020)
Figure 18. Global Alzheimer’s Therapeutic Revenue Market Share by Region in 2019
Figure 19. Global Alzheimer’s Therapeutic Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Alzheimer’s Therapeutic Revenue in 2019
Figure 21. Alzheimer’s Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Alzheimer’s Therapeutic Sales Market Share by Type (2015-2020)
Figure 23. Global Alzheimer’s Therapeutic Sales Market Share by Type in 2019
Figure 24. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2015-2020)
Figure 25. Global Alzheimer’s Therapeutic Revenue Market Share by Type in 2019
Figure 26. Global Alzheimer’s Therapeutic Market Share by Price Range (2015-2020)
Figure 27. Global Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
Figure 28. Global Alzheimer’s Therapeutic Sales Market Share by Application in 2019
Figure 29. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2015-2020)
Figure 30. Global Alzheimer’s Therapeutic Revenue Market Share by Application in 2019
Figure 31. North America Alzheimer’s Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Alzheimer’s Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Alzheimer’s Therapeutic Sales Market Share by Country in 2019
Figure 34. North America Alzheimer’s Therapeutic Revenue Market Share by Country in 2019
Figure 35. U.S. Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Alzheimer’s Therapeutic Market Share by Type in 2019
Figure 40. North America Alzheimer’s Therapeutic Market Share by Application in 2019
Figure 41. Europe Alzheimer’s Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Alzheimer’s Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Alzheimer’s Therapeutic Sales Market Share by Country in 2019
Figure 44. Europe Alzheimer’s Therapeutic Revenue Market Share by Country in 2019
Figure 45. Germany Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Alzheimer’s Therapeutic Market Share by Type in 2019
Figure 56. Europe Alzheimer’s Therapeutic Market Share by Application in 2019
Figure 57. Asia Pacific Alzheimer’s Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Alzheimer’s Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Region in 2019
Figure 60. Asia Pacific Alzheimer’s Therapeutic Revenue Market Share by Region in 2019
Figure 61. China Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Alzheimer’s Therapeutic Market Share by Type in 2019
Figure 84. Asia Pacific Alzheimer’s Therapeutic Market Share by Application in 2019
Figure 85. Latin America Alzheimer’s Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Alzheimer’s Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Alzheimer’s Therapeutic Sales Market Share by Country in 2019
Figure 88. Latin America Alzheimer’s Therapeutic Revenue Market Share by Country in 2019
Figure 89. Mexico Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Alzheimer’s Therapeutic Market Share by Type in 2019
Figure 96. Latin America Alzheimer’s Therapeutic Market Share by Application in 2019
Figure 97. Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Alzheimer’s Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Country in 2019
Figure 101. Turkey Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Alzheimer’s Therapeutic Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Alzheimer’s Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Alzheimer’s Therapeutic Market Share by Type in 2019
Figure 108. Middle East and Africa Alzheimer’s Therapeutic Market Share by Application in 2019
Figure 109. North America Alzheimer’s Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Alzheimer’s Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Alzheimer’s Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Alzheimer’s Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Alzheimer’s Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Alzheimer’s Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Alzheimer’s Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Alzheimer’s Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Alzheimer’s Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
アルツハイマー病の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer's Disease Scope and Market Size Alzheimer's Disease market is seg…- アルツハイマーの世界市場（～2026年） Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dement…
- アルツハイマー病治療法の世界市場（～2026年） Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with e…
- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- 濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…